Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A primary and a supplementary estimand were prespecified: the treatment regimen estimand reflected the treatment effect in the presence of predefined intercurrent events, including intake of obesity management medications prohibited by the protocol and early treatment discontinuation, and the efficacy estimand reflected the treatment effect as if all trial participants had adhered to treatment and had not received any obesity management medications prohibited by the protocol
Stimulate protein synthesis and prevent catabolism or loss of muscle mass
Tesamorelin appears to have an affinity to the GHRH receptors due to its chain composed of 44 amino acids, which include the specific sequence of GHRH, also made of 44 amino acids
Our injector, Deanna, will work closely with you to establish a personalized treatment plan
Product documentation may include batch-specific purity and identity information where available
The overall discontinuation rate due to side effects was 7%
US$ 22.35
US$ 28.19
US$ 22.51
US$ 27.06
US$ 20.83
US$ 20.52
